Will new IP policy ensure Sabka Vikas?
In our last issue, we highlighted Swati Spentose’s quiet rise to become a Rs 40-crore speciality API manufacturer
Author
Finding the hidden gems
Vishal Jajodia could sign up as a poster boy for Prime Minister Narendra Modi's Make In India campaign
Balancing the scales
Besides the balanced reasoning within the Delhi HC judgement, it is the SC's intervention which could see this case go down as a…
TC Biopharm to start phase II/III studies of ImmuniCell in October
Currently focused on skin, renal and lung cancer, the platform has potential to treat all types of cancer tumours as well as viral…
The Journey From Cow to Consumption
Post Diwali, ColoPlus sachets will be launched in India, thanks to a collaboration between ColoPlus and the Rs 1,450 crore…
Mainstreaming AYUSH
The last month saw a major milestone in the patent versus patient debate
The journey from cow to consumption
What does it take to transform bovine colostrum into a nutritional supplement, ensuring that all the immunoglobins, vitamins and…
Playing for high stakes
According to the latest data from the India Brand Equity Foundation (IBEF), the Indian domestic pharma market ended FY15 with a…
TC Biopharm to start phase II/III studies of ImmuniCell in October
Currently focused on skin, renal and lung cancer, the platform has potential to treat all types of cancer tumours as well as viral…
Mylan’s One Quality Standard a long way off
Some industry observers are surprised that ‘significant violations’ of this nature have not warranted an import alert or ban